Doença de Paget óssea

Referências

Principais artigos

Cooper C, Dennison E, Schafheutle K, et al. Epidemiology of Paget's disease of bone. Bone. 1999;24:3S-5S. Resumo

van Staa TP, Selby P, Leufkens HG, et al. Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res. 2002;17:465-471. Resumo

Singer FR, Bone HG 3rd, Hosking DJ, et al. Paget's disease of bone: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014 Dec;99(12):4408-22.Texto completo  Resumo

Whitehouse RW. Paget's disease of bone. Semin Musculoskelet Radiol. 2002 Dec;6(4):313-22. Resumo

Artigos de referência

1. Nance MA, Nuttall FQ, Econs MJ, et al. Heterogeneity in Paget disease of the bone. Am J Med Genet. 2000 Jun 19;92(5):303-7. Resumo

2. Hocking L, Slee F, Haslam SI, et al. Familial Paget's disease of bone: patterns of inheritance and frequency of linkage to chromosome 18q. Bone. 2000 Jun;26(6):577-80. Resumo

3. Siris ES, Ottman R, Flaster E, et al. Familial aggregation of Paget's disease of bone. J Bone Miner Res. 1991;6:495-500. Resumo

4. Morales-Piga AA, Rey-Rey JS, Corres-González J, et al. Frequency and characteristics of familial aggregation of Paget's disease of bone. J Bone Miner Res. 1995;10:663-670. Resumo

5. Eekhoff EW, Karperien M, Houtsma D, et al. Familial Paget's disease in The Netherlands: occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations. Arthritis Rheum. 2004;50:1650-1654. Resumo

6. Cooper C, Schaftheutle K, Dennison E, et al. The epidemiology of Paget's disease in Britain: is the prevalence decreasing? J Bone Miner Res. 1999;14:192-197. Resumo

7. Poor G, Donath J, Fornet B, et al. Epidemiology of Paget's disease in Europe: the prevalence is decreasing. J Bone Mineral Res. 2006;21:1545-1549. Resumo

8. Cooper C, Dennison E, Schafheutle K, et al. Epidemiology of Paget's disease of bone. Bone. 1999;24:3S-5S. Resumo

9. Altman RD, Bloch DA, Hochberg MC, et al. Prevalence of pelvic Paget's disease of bone in the United States. J Bone Miner Res. 2000;15:461-465. Resumo

10. van Staa TP, Selby P, Leufkens HG, et al. Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res. 2002;17:465-471. Resumo

11. Monsell EM, Cody DD, Bone HG, et al. Hearing loss as a complication of Paget's disease of bone. J Bone Miner Res. 1999;14:92-95. Resumo

12. McKusick VA. Heritable disorders of connective tissue. 4th ed. St. Louis: Mosby; 1972.

13. Siris E, Weinstein RS, Altman R, et al. Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. J Clin Endocrinol Metab. 1996 Mar;81(3):961-7. Resumo

14. Michou L, Collet C, Laplanche JL, et al. Genetics of Paget's disease of bone. Joint Bone Spine. 2006 May;73(3):243-8. Resumo

15. Albagha OM, Visconti MR, Alonso N, et al. Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone. Nat Genet. 2010 Jun;42(6):520-4. Resumo

16. Mee AP. Paramyxoviruses and Paget's disease: the affirmative view. Bone. 1999 May;24(5 suppl):19S-21S. Resumo

17. Gordon MT, Mee AP, Anderson DC, et al. Canine distemper virus transcripts sequenced from pagetic bone. Bone Miner. 1992 Nov;19(2):159-74. Resumo

18. Reddy SV, Singer FR, Mallette L, et al. Detection of measles virus nucleocapsid transcripts in circulating blood cells from patients with Paget disease. J Bone Miner Res. 1996 Nov;11(11):1602-7. Resumo

19. Ralston SH, Afzal MA, Helfrich MH, et al. Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of bone. J Bone Miner Res. 2007 Apr;22(4):569-77. Resumo

20. Kurihara N, Hiruma Y, Yamana K, et al. Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease. Cell Metab. 2011 Jan 5;13(1):23-34.Texto completo  Resumo

21. Helfrich MH, Hobson RP, Grabowski PS, et al. A negative search for a paramyxoviral etiology of Paget's disease of bone: molecular, immunological, and ultrastructural studies in UK patients. J Bone Miner Res. 2000 Dec;15(12):2315-29. Resumo

22. Lever JH. Paget's disease of bone in Lancashire and arsenic pesticide in cotton mill wastewater: a speculative hypothesis. Bone. 2002 Sep;31(3):434-6. Resumo

23. Lopez-Abente G, Morales-Piga A, Elena-Ibanez A, et al. Cattle, pets, and Paget's disease of bone. Epidemiology. 1997 May;8(3):247-51. Resumo

24. Siris ES, Kelsey JL, Flaster E, et al. Paget's disease of bone and previous pet ownership in the United States: dogs exonerated. Int J Epidemiol. 1990 Jun;19(2):455-8. Resumo

25. Demulder A, Takahashi S, Singer FR, et al. Abnormalities in osteoclast precursors and marrow accessory cells in Paget's disease. Endocrinology. 1993 Nov;133(5):1978-82. Resumo

26. Winfield J, Stamp TC. Bone and joint symptoms in Paget's disease. Ann Rheum Dis. 1984 Dec;43(6):769-73.Texto completo  Resumo

27. Parvizi J, Restrepo C, Sim FH. Paget's disease of the hip: surgical management. Future Rheumatology. 2006;1:373-7.

28. Yost JH, Spencer-Green G, Krant JD. Vascular steal mimicking compression myelopathy in Paget's disease of bone: rapid reversal with calcitonin and systemic steroids. J Rheumatol. 1993 Jun;20(6):1064-5. Resumo

29. Singer FR, Bone HG 3rd, Hosking DJ, et al. Paget's disease of bone: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014 Dec;99(12):4408-22.Texto completo  Resumo

30. Whitehouse RW. Paget's disease of bone. Semin Musculoskelet Radiol. 2002 Dec;6(4):313-22. Resumo

31. Avramidis A, Polyzos SA, Moralidis E, et al. Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone. J Bone Miner Metab. 2008;26(6):635-41. Resumo

32. Delmas PD, Meunier PJ. The management of Paget's disease of bone. N Engl J Med. 1997 Feb 20;336(8):558-66. Resumo

33. Eekhoff ME, van der Klift M, Kroon HM, et al. Paget's disease of bone in The Netherlands: a population-based radiological and biochemical survey--The Rotterdam Study. J Bone Miner Res. 2004 Apr;19(4):566-70. Resumo

34. Alvarez L, Guanabens N, Peris P, et al. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease. J Bone Miner Res. 1995 Mar;10(3):458-65. Resumo

35. Rubin DJ, Levin RM. Neurologic complications of Paget disease of bone. Endocr Pract. 2009 Mar;15(2):158-66. Resumo

36. Eisman JA, Martin TJ. Osteolytic Paget's disease: recognition and risks of biopsy. J Bone Joint Surg Am. 1986 Jan;68(1):112-7. Resumo

37. Langston AL, Campbell MK, Fraser WD, et al. Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget's disease of bone. J Bone Miner Res. 2010 Jan;25(1):20-31. Resumo

38. Reid IR, Lyles K, Su G, et al. A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years. J Bone Miner Res. 2011 Sep;26(9):2261-70.Texto completo  Resumo

39. Doyle FH, Pennock J, Greenberg PB, et al. Radiological evidence of a dose-related response to long-term treatment of Paget's disease with human calcitonin. Br J Radiol. 1974 Jan;47(553):1-8. Resumo

40. Reid IR, Sharma S, Kalluru R, et al. Treatment of Paget's Disease of Bone with Denosumab: Case Report and Literature Review. Calcif Tissue Int. 2016 Sep;99(3):322-5. Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal